Abstract
Biotech innovations’ patenting procedure in India encounters substantial procedural obstacles. This article provides a wide spectrum analysis of critical factors affecting the patent application process, specifically addressing subject matter eligibility, innovative steps, adequacy of disclosure, and delays in examination and backlog. These problems significantly impact the biotechnology business and startups, resulting in commercialization market delays, reduced competitiveness, and restricted research and development (R&D) efforts. This research highlights the need for action from stakeholders, policymakers, legislators, and the biotechnology community while offering solutions via case studies and analytical insights. Legislative amendments, adopting global best practices, improvements to the examination procedure, backlog reduction strategies, and more stakeholder involvement are among the suggestions. These procedural hindrances must be resolved in order to develop a vibrant and competitive biotechnology industry in India, promote more R&D activity, boost economic development, and successfully tackle global problems.
Get full access to this article
View all access options for this article.